Alpha Centric Advisors LLC Exact Sciences Corp Transaction History
Alpha Centric Advisors LLC
- $97.4 Million
- Q4 2024
A detailed history of Alpha Centric Advisors LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 11,790 shares of EXAS stock, worth $571,697. This represents 0.68% of its overall portfolio holdings.
Number of Shares
11,790
Previous 30,000
60.7%
Holding current value
$571,697
Previous $2.04 Million
67.58%
% of portfolio
0.68%
Previous 1.73%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
644Shares Held
157MCall Options Held
1.83MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$865 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$855 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$606 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$585 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$321 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.58B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...